Portage Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
May 1 12:44 ET
Portage Biotech | 424B3: Prospectus
May 1 12:44 ET
Portage Biotech | 424B3: Prospectus
Apr 12 17:28 ET
Portage Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 12 17:24 ET
Portage Biotech | 424B3: Prospectus
Mar 8 17:32 ET
Portage Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 8 17:07 ET
Portage Biotech | 424B3: Prospectus
Mar 7 06:04 ET
Portage Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 7 06:04 ET
Portage Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 29 12:00 ET
Portage Biotech | 424B3: Prospectus
Feb 28 22:44 ET
Portage Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 28 22:44 ET
Portage Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Feb 14 15:54 ET
Portage Biotech | 424B3: Prospectus
Jan 19 00:00 ET
Portage Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 18 00:00 ET
Portage Biotech | 424B3: Prospectus
Jan 5 00:00 ET
Portage Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 4 00:00 ET
Portage Biotech | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Dec 1, 2023 16:05 ET
Portage Biotech | 424B3: Prospectus
Nov 28, 2023 16:03 ET
Portage Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 28, 2023 16:02 ET
Portage Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 28, 2023 16:01 ET
No Data
No Data